Simplex Trading’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$435K Sell
31,776
-113,601
-78% -$1.55M ﹤0.01% 3741
2026
Q2
$1.97M Buy
+145,377
New +$1.74M ﹤0.01% 2059
2025
Q3
– Sell
-1,608
Closed -$15.8K – 9767
2025
Q2
$15K Buy
+1,608
New +$16.6K ﹤0.01% 7019
2025
Q1
– Sell
-84,541
Closed -$1.3M – 9310
2024
Q4
$1.26M Sell
84,541
-7,606
-8% -$124K ﹤0.01% 2622
2024
Q3
$1.76M Buy
92,147
+20,561
+29% +$426K ﹤0.01% 2390
2024
Q2
$1.48M Sell
71,586
-64,832
-48% -$1.29M ﹤0.01% 2501
2024
Q1
$2.56M Buy
136,418
+6,323
+5% +$109K ﹤0.01% 2156
2023
Q4
$1.88M Buy
+130,095
New +$1.77M ﹤0.01% 2421
2023
Q2
– Sell
-19,295
Closed -$419K – 9644
2023
Q1
$453K Buy
+19,295
New +$518K ﹤0.01% 3377
2022
Q4
– Sell
-10,302
Closed -$263K – 10057
2022
Q3
$241K Buy
+10,302
New +$311K ﹤0.01% 4378
2022
Q2
– Sell
-2,444
Closed -$85.6K – 10742
2022
Q1
$85K Buy
+2,444
New +$83.6K ﹤0.01% 6381
2021
Q4
– Sell
-10,485
Closed -$342K – 11142
2021
Q3
$323K Buy
10,485
+2,651
+34% +$84.8K ﹤0.01% 4789
2021
Q2
$237K Buy
+7,834
New +$258K ﹤0.01% 5404

Other funds holding OGN

Simplex Trading's OGN Position: Q3 2026 in Review

Simplex Trading reduced its Organon & Co (OGN) stake by 78% in Q3 2026, selling an estimated $1.55M and leaving 31,776 shares worth $435K. The position accounts for ﹤0.01% of the portfolio, ranked #3741.

Simplex Trading first reported a position in OGN in Q2 2021 and has held it in 13 quarters since. The position peaked at $2.56M in Q1 2024. 359 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Simplex Trading held 31,776 shares of Organon & Co worth $435K as of Q3 2026.
  • Simplex Trading sold 113,601 Organon & Co shares in Q3 2026, an estimated $1.55M.
  • Organon & Co made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #3741 holding.
  • Simplex Trading first reported a position in Organon & Co in Q2 2021 and has held it in 13 quarters since.
  • Simplex Trading's Organon & Co position peaked at $2.56M in Q1 2024.
  • 359 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.